Investors looking for stocks that combine strong technical trends with accelerating fundamental growth may find a candidate in NeurAxis Inc (NYSEARCA:NRXS). This approach, inspired by Mark Minervini’s proven methodology, seeks to identify securities that not only show a clear uptrend but also display improving earnings and revenue momentum. By filtering for stocks that meet the Minervini Trend Template and carry a High Growth Momentum (HGM) rating of at least 4, we aim to surface companies where institutional buying, strong relative strength, and solid business performance align.
Recent Performance and Trend Health
NeurAxis has shown strong momentum over the past year. The stock currently trades at $7.28, a significant recovery from its 52-week low of $1.942. Over the last 12 months, it has surged approximately 198%, outperforming 97% of all stocks in the market. This performance is not just a spike — the gains have been distributed steadily, with a 108.6% rise over six months and a 49.8% gain in the last three months. Even after a slight pullback of -0.41% in the last month, the long-term and short-term trends remain positive.
The ChartMill technical rating of 10/10 confirms this strength. The stock sits well above all key moving averages:
- Current price ($7.28) is above the 50-day SMA ($6.39), the 150-day SMA ($4.37), and the 200-day SMA ($3.91).
- The 200-day SMA is rising, currently at $3.91 versus $3.88 in the prior period, confirming a sustained uptrend.
- The 50-day SMA is above both the 150-day and 200-day SMAs, a classic bullish alignment.
Relative strength is also elite: a score of 97.16 means NRXS outperforms 97% of all stocks, reinforcing that it is a market leader.
Fitting the Minervini Trend Template
The Minervini Trend Template uses eight specific criteria to confirm a stock is in a strong, stage-2 uptrend. NRXS meets every one based on current data:
- Price above 150-day and 200-day MAs – Yes, by a wide margin.
- 150-day and 200-day MAs trending upward – Confirmed.
- 50-day MA above 150-day and 200-day MAs – Yes, 6.39 > 4.37 and 6.39 > 3.91.
- Current price at least 30% above 52-week low – At $7.28 vs. $1.94, the stock is 275% above the low.
- Current price within 25% of 52-week high – $7.28 is within 8.6% of the 52-week high of $7.97.
- Relative strength above 70 – At 97.16, it far exceeds the threshold.
These criteria confirm that NRXS is not just recovering but is actively being accumulated by institutions. The stock’s ability to trade near its highs while maintaining a rising moving average structure is exactly what the Minervini method targets — a stock in the early to middle stages of a major uptrend.
High Growth Fundamentals
For growth investors, the fundamental picture is equally encouraging. The company is still in a growth phase, but the trajectory is clearly upward.
Earnings momentum:
- EPS (TTM) remains negative at -$0.96, but the improvement rate is notable. EPS growth over the last TTM year is +20.3%.
- The most recent quarter (Q2Q) showed EPS growth of +19%, following a +4% gain in the prior quarter and a +47.6% jump two quarters ago.
- The EPS estimate for the next quarter points to +39.7% growth, suggesting the acceleration is expected to continue.
Revenue acceleration:
- Revenue grew 32.9% over the last TTM year, a sharp acceleration from 9.2% in the prior year.
- The most recent quarter’s revenue rose 27.4% year-over-year, with estimates for the next quarter calling for +59.4% growth.
- Revenue beat estimates in one of the last four quarters, but the average beat percentage of -29.9% suggests room for improvement.
Revision activity:
- Analysts have raised next-year EPS estimates by +4.4% and revenue estimates by +16.5% over the past three months. This upward revision trend is a key sign that the business is gaining traction.
These fundamental signals align with the high-growth criteria Minervini emphasizes: accelerating earnings and revenue, positive estimate revisions, and improving sales growth. While the company is not yet profitable on a GAAP basis, the pace of improvement is what growth investors typically seek.
Technical Setup and Risk Management
The ChartMill setup quality score of 8/10 indicates that NRXS is currently forming a constructive consolidation pattern. The technical report highlights a key support zone between $7.04 and $7.14, supported by multiple trend lines and moving averages. Resistance sits at $7.41, a horizontal line from the daily timeframe.
A potential trade setup based on this structure suggests:
- Entry: $7.42 (buy stop above resistance)
- Stop loss: $7.03 (below support)
- Maximum loss: 5.26% of the position
This tight range, combined with the stock’s excellent technical rating, makes it a candidate for disciplined breakout traders. The presence of large players (as measured by effective volume) adds further confidence.
For more details on the technical analysis, view the full report here.
Analyst Views
While specific analyst ratings are not provided, the upward earnings and revenue revisions suggest that the sell-side is becoming more optimistic. The combination of strong price action, rising estimates, and sector leadership (NRXS outperforms 98% of stocks in the Health Care Equipment & Supplies industry) creates a favorable backdrop.
Screen for More Opportunities
The approach used to identify NeurAxis is systematic and repeatable. If you want to explore other stocks that meet these same criteria — Minervini Trend Template and High Growth Momentum — you can run the full screen using this link. Use it to discover additional candidates with similar technical and fundamental profiles.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider your risk tolerance before making trading decisions.